ARCHIVES

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

July 25, 1975

DCT Board Ok’s $10.6 Mil. Renewal Of CTEP Contract

November 2, 1990

Ethics Commission Backs Limited Pilot Program for Compensation Of Injured Research Subjects

January 16, 1981

O’Connor Is New NS President, Curtiss Is Next

May 24, 1991

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

U.S., Japan Establish Joint AIDS Panel

August 14, 1987